Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham
Anissa
A
Guillin
Olivier
O
D014150:Antipsychotic Agents / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D009446:Neurobiology / Q000379:methods / Q000639:trends; D009480:Neuropharmacology / Q000379:methods / Q000639:trends; D018377:Neurotransmitter Agents / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism*; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
D014150:Antipsychotic Agents; D018377:Neurotransmitter Agents; D017448:Receptors, Dopamine D2; D017981:Receptors, Neurotransmitter; D004298:Dopamine